Articles > Popular publications > PR Newswire press releases > April-June 2008 > Thursday, June 5

Article: Micromet's BiTE Antibody Blinatumomab (MT103/MEDI-538) Demonstrates Durable Responses in Patients with Relapsed Non-Hodgkin's Lymphoma.

Article from:
PR Newswire
Article date:
June 5, 2008
Copyright

Interim Phase 1 Data Presented at International Conference on Malignant Lymphomas Shows Dose Dependent Single Agent Activity

BETHESDA, Md., June 5 /PRNewswire-FirstCall/ -- Micromet, Inc. , a biopharmaceutical company developing novel, proprietary antibodies for the treatment of cancer, inflammation and autoimmune diseases, today presented an update of an ongoing phase 1 clinical trial for its BiTE(R) antibody blinatumomab (MT103/MEDI-538) at the 10th International Conference on Malignant Lymphomas (ICML) in Lugano, Switzerland. The new data(1) with the CD19-specific BiTE antibody show that all seven patients in the highest dose cohort tested so far (0.06 ...

Read all of this article with a FREE trial

Related newspaper, magazine, and journal articles:

Article: Micromet Demonstrates That the Antibodies in Commercial Products ...
PR Newswire;  April 14, 2008 ;     700+ words ... ... converted into a BiTE antibody. BiTE antibodies are designed ... pipeline are BiTE antibodies and have ... proprietary BiTE antibody platform ... the first BiTE antibody with potential ... additional BiTE antibodies, targeting ...

Article: Bayer Schering Exercises Option to Develop Solid Tumor ...
PR Newswire;  December 1, 2009 ;     700+ words ... ... sales of the BiTE antibody. In addition ... expenses. "BiTE antibodies represent ... promise of our BiTE antibody platform." About BiTE Antibodies BiTE[R ... several novel BiTE antibodies generated ... proprietary BiTE antibody platform ...

Article: Micromet Announces Presentation of Five Posters Related to Its ...
PR Newswire;  March 18, 2008 ;     700+ words ... ... advancing the BiTE antibody platform ... a novel human BiTE antibody platform, demonstrate that BiTE antibodies can be delivered ... highly active BiTE antibodies." References ... EpCAM-specific BiTE Antibody MT110. Annual ...

Article: Micromet Enters Into Agreement for Solid Tumor BiTE ...
PR Newswire;  January 12, 2009 ;     700+ words ... ... s preclinical BiTE antibodies against an undisclosed ... on a specific BiTE antibody. Bayer Schering ... validation of our BiTE antibody technology by ... about Micromet's BiTE antibody technology and believe BiTE antibodies represent a novel ...

Article: Micromet Presents Preclinical Data Showing Activity of Erbitux ...
PR Newswire;  April 22, 2009 ;     700+ words ... ... Micromet's EGFR BiTE antibodies were able to ... daily EGFR BiTE antibody doses as low ... very potent EGFR BiTE antibodies. Based on these ... EGFR-directed BiTE antibody for the treatment ... to license a BiTE antibody against an undisclosed ... Additional ...

Article: Micromet Presents Safety and Efficacy Data from Primate Studies ...
PR Newswire;  April 14, 2008 ;     700+ words ... ... anti-MCSP BiTE antibodies used a novel human BiTE antibody platform ... these two new BiTE antibodies that continue ... our novel BiTE antibody pipeline ... pipeline are BiTE antibodies and have ... proprietary BiTE antibody platform ...

Article: Micromet Receives European Orphan Drug Designation for Treatment ...
PR Newswire;  August 3, 2009 ;     700+ words ... ... its proprietary BiTE antibody platform, as ... antibodies. BiTE antibodies represent a new ... several novel BiTE antibodies generated with its proprietary BiTE antibody platform technology ... license a specified BiTE antibody against an undisclosed ... target. ...

Article: Micromet to Present Six Posters on Progress of BiTE ...
PR Newswire;  March 16, 2009 ;     700+ words ... ... T cell-engaging BiTE antibodies derived from anti ... CD3-bispecific BiTE antibody MT110. AACR Annual ... T cell-engaging BiTE antibody MT110. AACR Annual ... Pharma AG to license a BiTE antibody against an undisclosed ... target. Additional BiTE antibodies, ...

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!

Find articles, research, and archives